AD-BMT©
The AD-BMT© Program, launched in 2020, offers a comprehensive and accessible approach to autologous and allogeneic hematopoietic stem cell transplantation (HSCT) for both adults and children in the UAE. Aligned with national healthcare strategies, the program prioritizes innovation, research, and the vision of enhancing the health sector's competitiveness by 2071. With a focus on clinical care, advanced research, education, apheresis, cell processing, cryopreservation, and bone marrow registry, the AD-BMT© Program creates an integrated ecosystem to deliver state-of-the-art cell therapy services.
CAR-T Cells Engineering
ADSCC’s CAR-T Cells program is dedicated to engineering ground-breaking and innovative treatments for blood cancers in the UAE and the region. By providing advanced therapies locally, we eliminate the need for patients to travel abroad, resulting in reduced healthcare expenditures. With the largest GMP lab in the UAE and the region, we have a manufacturing capacity of 200 CAR-T cell products per year, including virus-specific T cells, genetically engineered TCR receptors, and gene therapy. By combining the best manufacturing practices, cutting-edge research, and exceptional expertise, we strive to achieve remarkable outcomes and establish a robust CAR-T Cell treatment program in Abu Dhabi.
Multiple Sclerosis
ADSCC’s Multiple Sclerosis Program is to evaluate the safety of extracorporal photopheresis (ECP) in the treatment of Multiple Sclerosis. Extracorporal Photopheresis (ECP) is a treatment method used primarily for immune disorders. The process involves extracting a patient’s white blood cells, treating them with a chemical and light exposure, and reintroducing them into the body to regulate the immune response. ECP has been used to treat conditions such as cutaneous T cell lymphoma, graft-versus-host disease, and organ transplant rejection.
Multiple Sclerosis
ADSCC’s Multiple Sclerosis Program is to evaluate the safety of extracorporal photopheresis (ECP) in the treatment of Multiple Sclerosis. Extracorporal Photopheresis (ECP) is a treatment method used primarily for immune disorders. The process involves extracting a patient’s white blood cells, treating them with a chemical and light exposure, and reintroducing them into the body to regulate the immune response. ECP has been used to
e
